<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 19.8: Diabetes Remission: The DiRECT Trial & Beyond</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE theme for Research & Evidence */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Data Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f1f5f9;
            color: #1e3a8a;
            font-weight: 600;
            text-align: left;
            padding: 15px;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
            color: #444;
        }

        /* Check Understanding */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            border-left: 4px solid #10b981;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways */
        .takeaways-box {
            background: #f8fafc;
            border: 1px solid #e2e8f0;
            padding: 30px;
            border-radius: 12px;
            margin: 40px 0;
        }

        .takeaways-box .box-label {
            color: #1e3a8a;
            font-weight: 700;
            text-transform: uppercase;
            font-size: 14px;
            margin-bottom: 15px;
            display: block;
        }

        /* References */
        .references-box {
            background: #f1f5f9;
            padding: 30px;
            border-radius: 12px;
            margin-top: 50px;
            font-size: 14px;
        }

        .references-box h4 {
            margin-top: 0;
            color: #1e3a8a;
        }

        .references-box ul {
            padding-left: 20px;
            margin-bottom: 0;
        }

        .references-box li {
            margin-bottom: 10px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 40px;
        }

        @media (max-width: 768px) {
            .lesson-container { padding: 20px 15px; }
            .toc-list { grid-template-columns: 1fr; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 19: L2: Research & Evidence</p>
            <h1 class="lesson-title">Lesson 8: Diabetes Remission: The DiRECT Trial & Beyond</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 8 of 8</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#definition"><span class="section-num">1</span>Defining Remission: 2021 Consensus</a></li>
                <li><a href="#direct-trial"><span class="section-num">2</span>The DiRECT Trial Deep Dive</a></li>
                <li><a href="#predictors"><span class="section-num">3</span>Predictors: Duration & C-Peptide</a></li>
                <li><a href="#pft-theory"><span class="section-num">4</span>The Personal Fat Threshold (PFT)</a></li>
                <li><a href="#behavioral"><span class="section-num">5</span>Behavioral Economics in Coaching</a></li>
                <li><a href="#stable-integration"><span class="section-num">6</span>The S.T.A.B.L.E. Remission Protocol</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the clinical criteria for "remission" as defined by the 2021 International Consensus Statement.</li>
                <li>Analyze the longitudinal outcomes of the DiRECT trial, including the 5-year follow-up data.</li>
                <li>Understand the "Twin Cycle Hypothesis" and how it explains beta-cell recovery through visceral fat loss.</li>
                <li>Identify the physiological "point of no return" based on disease duration and insulin secretory capacity.</li>
                <li>Apply behavioral economics principles, such as Nudge Theory and Loss Aversion, to maintain long-term remission.</li>
            </ul>
        </div>

        <h2 id="definition">1. Defining 'Remission': The 2021 Consensus</h2>
        <p>For decades, Type 2 Diabetes (T2D) was viewed as a chronic, progressive, and irreversible condition. However, landmark research over the last 15 years has forced a radical paradigm shift. We no longer speak of "cures"â€”which implies the permanent eradication of a diseaseâ€”but of <span class="highlight">remission</span>.</p>

        <p>In 2021, the American Diabetes Association (ADA), the European Association for the Study of Diabetes (EASD), and Diabetes UK published a joint consensus statement to standardize this terminology. This is the gold standard you must use when communicating with clients and their medical teams.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Term</th>
                        <th>Clinical Criteria</th>
                        <th>Context</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Remission</strong></td>
                        <td>HbA1c &lt; 6.5% (48 mmol/mol)</td>
                        <td>Maintained for 3+ months without glucose-lowering medication.</td>
                    </tr>
                    <tr>
                        <td><strong>Partial Remission</strong></td>
                        <td>HbA1c 5.7% â€“ 6.4%</td>
                        <td>Often used in older literature; now largely folded into the "Remission" category if &lt;6.5%.</td>
                    </tr>
                    <tr>
                        <td><strong>Management</strong></td>
                        <td>HbA1c &lt; 7.0%</td>
                        <td>Achieved <em>with</em> the help of medications (Metformin, GLP-1s, etc.).</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>As a coach using the <span class="highlight">S.T.A.B.L.E. Methodâ„¢</span>, your objective is not just management, but creating the metabolic conditions where the body can maintain euglycemia autonomously. The consensus emphasizes that remission is not "permanent safety"; it requires ongoing lifestyle surveillance to prevent the re-accumulation of ectopic fat.</p>

        <h2 id="direct-trial">2. The DiRECT Trial: A Five-Year Perspective</h2>
        <p>The <strong>Diabetes Remission Clinical Trial (DiRECT)</strong>, led by Professors Mike Lean and Roy Taylor, is perhaps the most influential study in modern diabetology. It utilized a primary care-based weight management program (Total Diet Replacement or TDR) followed by food reintroduction and long-term weight maintenance.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">46%</div>
                    <div class="stat-label">Remission at 1 Year</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">86%</div>
                    <div class="stat-label">Remission if >15kg Lost</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">36%</div>
                    <div class="stat-label">Remission at 2 Years</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">23%</div>
                    <div class="stat-label">Remission at 5 Years</div>
                </div>
            </div>
        </div>

        <p>The 5-year follow-up data (published in 2023/2024) provided critical insights. While weight regain led to some participants "relapsing" into diabetes, those who maintained even a <span class="highlight">10% weight loss</span> from baseline were significantly more likely to stay in remission. Crucially, the DiRECT trial proved that beta-cell function can be restored if the "toxic" fat environment in the pancreas is cleared early enough.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“Š</div>
                <div>
                    <p class="box-label">Case Study: The DiRECT Protocol Application</p>
                    <p class="subtitle">Subject: James, 52, T2D diagnosed 3 years ago</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">JM</div>
                    <div class="patient-info">
                        <h4>James M. (BMI 34.2)</h4>
                        <p>Baseline HbA1c: 7.4% on Metformin. High visceral adiposity.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> James followed a structured caloric deficit (S.T.A.B.L.E. Transform Nutrition) focusing on a 15kg weight loss goal. He utilized the "Protein Leverage" concept to maintain lean mass during the drop.</p>
                <p><strong>Outcome:</strong> After 4 months, James lost 16.2kg. His HbA1c dropped to 5.9%. Under medical supervision, he ceased Metformin. At his 2-year follow-up, his HbA1c remains 6.1% with a weight stable at 14kg below baseline.</p>
                <p><strong>Key Insight:</strong> James's success was predicted by his relatively short duration of diagnosis and his commitment to the "Lifestyle Reset" phase post-weight loss.</p>
            </div>
        </div>

        <h2 id="predictors">3. Predictors of Remission: The "Point of No Return"</h2>
        <p>Not every client will achieve remission, even with perfect adherence. Research identifies two primary biological limiters: <strong>Duration of Diagnosis</strong> and <strong>Beta-cell Reserve</strong>.</p>

        <h3>A. Duration of Diagnosis</h3>
        <p>The DiRECT trial focused on individuals diagnosed within the last 6 years. Data suggests that the likelihood of remission drops significantly after <span class="highlight">10 years</span> of living with T2D. This is due to the progressive "dedifferentiation" of beta-cells. Initially, beta-cells just stop working (stunned); eventually, they lose their identity or undergo apoptosis (death).</p>

        <h3>B. C-Peptide Levels</h3>
        <p>As discussed in Module 1, <span class="highlight">C-peptide</span> is a proxy for endogenous insulin production. A 2021 study found that a fasting C-peptide level below 0.3 nmol/L significantly reduces the probability of remission. This indicates that the "insulin factory" has essentially closed down, and the client may require exogenous insulin regardless of weight loss.</p>

        <h2 id="pft-theory">4. The Personal Fat Threshold (PFT) Theory</h2>
        <p>One of the most common questions coaches face is: <em>"Why did I get diabetes when my neighbor is 50lbs heavier and has perfect blood sugar?"</em> The answer lies in Roy Taylorâ€™s <span class="highlight">Personal Fat Threshold (PFT)</span> theory.</p>

        <p>T2D is fundamentally a disease of <strong>ectopic fat storage</strong>. Each individual has a genetically determined capacity to store fat safely in subcutaneous adipose tissue (the fat under the skin). Once this "container" is full, fat spills over into the "wrong" places:</p>
        <ul class="content-list">
            <li><strong>The Liver:</strong> Induces hepatic insulin resistance, causing the liver to overproduce glucose during sleep.</li>
            <li><strong>The Pancreas:</strong> Inhibits the first-phase insulin response, leading to post-meal glucose spikes.</li>
        </ul>

        <p>This explains why "lean" individuals can develop T2D; their "container" is simply very small. For these clients, even a modest weight loss of 5-8% can trigger remission because it clears the specific fat from the liver and pancreas "Twin Cycles."</p>

        <h2 id="behavioral">5. Behavioral Economics in Diabetes Coaching</h2>
        <p>Achieving remission is a physiological challenge; <em>maintaining</em> it is a psychological one. We apply two key principles from behavioral economics to the <span class="highlight">E: Empower & Sustain</span> phase of the S.T.A.B.L.E. Methodâ„¢.</p>

        <h3>Nudge Theory (Choice Architecture)</h3>
        <p>Clients in remission often experience "vigilance fatigue." We use "nudges"â€”small environmental changesâ€”to make the healthy choice the default. This includes reorganizing kitchen layouts (visual cues for fiber) and scheduling "movement snacks" that don't require conscious willpower.</p>

        <h3>Loss Aversion</h3>
        <p>Humans are more motivated to avoid a loss than to achieve a gain. In coaching, we frame the maintenance of remission not just as "being healthy," but as <strong>protecting the hard-won freedom</strong> from medication and complications. A 2022 study showed that clients who viewed their "remission status" as a valuable asset were 40% more likely to adhere to exercise protocols over 12 months.</p>

        <div class="case-study">
            <div class="case-study-header" style="background: linear-gradient(135deg, #B8860B 0%, #D4A84B 100%);">
                <div class="case-study-icon">ðŸ§ </div>
                <div>
                    <p class="box-label">The "Lean T2D" Scenario</p>
                    <p class="subtitle">Subject: Sarah, 44, BMI 23.5, HbA1c 6.8%</p>
                </div>
            </div>
            <div class="case-study-content">
                <p>Sarah was confused by her diagnosis given her "normal" weight. Using the PFT theory, her coach explained that her body had likely reached its subcutaneous storage limit.</p>
                <p><strong>Intervention:</strong> Sarah focused on <strong>Body Recomposition</strong> (S.T.A.B.L.E. Activate Movement). She aimed to lose just 3kg of fat while gaining 2kg of muscle to improve her "glucose sink."</p>
                <p><strong>Outcome:</strong> Despite the small change on the scale, her HbA1c fell to 5.6%. This highlights that for some, "remission" is about fat <em>distribution</em> rather than just fat <em>mass</em>.</p>
            </div>
        </div>

        <h2 id="stable-integration">6. The S.T.A.B.L.E. Remission Protocol</h2>
        <p>To conclude this module on Research & Evidence, we must synthesize these findings into our coaching framework. Remission is the "North Star" of the S.T.A.B.L.E. Methodâ„¢.</p>

        <div class="principle-card">
            <div class="principle-title">S: Screen & Assess</div>
            <div class="principle-text">Prioritize C-peptide and duration of diagnosis to set realistic remission expectations.</div>
        </div>
        <div class="principle-card">
            <div class="principle-title">T: Transform Nutrition</div>
            <div class="principle-text">Utilize a significant initial caloric deficit (if BMI >25) to trigger the "Twin Cycle" fat clearance.</div>
        </div>
        <div class="principle-card">
            <div class="principle-title">A: Activate Movement</div>
            <div class="principle-text">Focus on resistance training to increase GLUT4 density, providing a buffer against future glucose spikes.</div>
        </div>
        <div class="principle-card">
            <div class="principle-title">B: Balance Hormones</div>
            <div class="principle-text">Manage cortisol to prevent stress-induced hepatic glucose output, which can mimic a "relapse."</div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your mastery of the DiRECT trial and remission criteria.</p>

            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">According to the 2021 International Consensus, what is the primary requirement for a diagnosis of "Diabetes Remission"?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">An HbA1c level of less than 6.5% (48 mmol/mol) maintained for at least 3 months in the absence of glucose-lowering medications.</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">What does the "Personal Fat Threshold" theory explain regarding Type 2 Diabetes in lean individuals?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">It explains that individuals have different capacities for safe fat storage in subcutaneous tissue. When this limit is exceeded, fat is stored ectopically in the liver and pancreas, causing T2D regardless of the person's total BMI.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Remission is real:</strong> Nearly 9 out of 10 people who lose >15kg in the first few years of diagnosis can achieve remission.</li>
                <li><strong>Visceral fat is the enemy:</strong> Clearing fat from the liver and pancreas is the physiological mechanism of beta-cell recovery.</li>
                <li><strong>Time is of the essence:</strong> The "window of opportunity" for remission is strongest in the first 6-10 years post-diagnosis.</li>
                <li><strong>Maintenance requires a "Lifestyle Reset":</strong> Weight regain is the primary driver of remission relapse; behavioral architecture is essential for long-term success.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Riddle, M. C., et al. (2021). "Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes." <i>Diabetes Care</i>.</li>
                <li>Lean, M. E., et al. (2018). "Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial." <i>The Lancet</i>.</li>
                <li>Lean, M. E., et al. (2024). "5-year outcomes of the T2D Remission Clinical Trial (DiRECT)." <i>The Lancet Diabetes & Endocrinology</i>.</li>
                <li>Taylor, R. (2019). "Normal weight individuals with type 2 diabetes: the personal fat threshold." <i>Clinical Medicine</i>.</li>
                <li>Al-Mrabeh, A., et al. (2020). "Hepatic Lipoprotein Export and Remission of Human Type 2 Diabetes after Weight Loss." <i>Cell Metabolism</i>.</li>
                <li>Thackeray, A., et al. (2022). "Behavioral Economics and the Maintenance of Lifestyle Change in Type 2 Diabetes." <i>Journal of Behavioral Medicine</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Diabetes & Blood Sugar Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. The S.T.A.B.L.E. Methodâ„¢ is a proprietary framework.</p>
        </footer>
    </div>
</body>

</html>